$BCAX took 1.5g weekly into ph3, but now says 2g Q2W is better, reducing frequency & maintaining efficacy. But that's not even the final dose! That's Q3W, which they've not even tested. And no change to 1.5g in ph3, but new doses "increase confidence in pivotal study". Wild! https://t.co/5gOVF4tuEI

